Endocrinologists and cardiologists in major cities are gaining experience with GLP-1 medications through diabetes management applications, facilitating confidence in prescribing for obesity indications
Medical review before treatment selection Nutrition, insulin resistance, and hormonal balance Therapy prescribed and monitored by medical providers Medical weight loss is a clinically guided approach to improving body composition and metabolic health by addressing the physiological systems that influence appetite, energy balance, and fat storage
Visible weight loss begins appearing around weeks 6-8 as cumulative loss reaches 8-12 pounds
In clinical trials, participants who started at 2mg and escalated every 4 weeks through 4mg, 8mg, and finally 12mg experienced a gradual onset of appetite suppression
Although published clinical trials have reported favorable metabolic findings [1], these results relate to investigational retatrutide studied under regulated conditions
Yet, despite these benefits, insurance companies are reluctant to pay for treatments that can help people achieve lasting weight loss
